Patents by Inventor Ludovic BUSSARD

Ludovic BUSSARD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATING ACNE
    Publication number: 20140309198
    Abstract: An improved method for treating acne is described. The method involves 16-week, once daily, oral administration of about 40 mg doxycycline in a pharmaceutical composition containing about 30 mg doxycycline in an immediate release portion and about 10 mg doxycycline in a delayed release portion. It was surprisingly discovered that the 16-week, once daily, oral administration of about 40 mg doxycycline has achieved same or superior efficacy than that of 100 mg doxycycline, but with a significant reduction in adverse events.
    Type: Application
    Filed: April 4, 2014
    Publication date: October 16, 2014
    Inventors: Vasant Kumar MANNA, Sandrine SEGURA, Ludovic BUSSARD, Jean-Pierre ETCHEGARAY, Philip FREIDENREICH
  • SUSTAINED-RELEASE TABLET AND PROCESS FOR PREPARING THE SAME
    Publication number: 20140199469
    Abstract: A method for producing a sustained-release tablet having improved stability and content uniformity is provided. The method involves first preparing a core tablet by granulating, drying, milling, blending, and compressing a mixture of active and inactive ingredients. Four coating layers are applied to the core tablet: an inner layer, an enteric coating layer, an active layer, and an outer layer. The active ingredient may be a tetracycline, such as doxycycline. A sustained-release tablet prepared according to the method is also described.
    Type: Application
    Filed: February 25, 2014
    Publication date: July 17, 2014
    Applicant: Galderma S.A.
    Inventors: Sandrine SEGURA, Ludovic BUSSARD, Jean-Pierre ETCHEGARAY
  • METHOD OF TREATING ACNE
    Publication number: 20130196954
    Abstract: An improved method for treating acne is described. The method involves 16-week, once daily, oral administration of about 40 mg doxycycline in a pharmaceutical composition containing about 30 mg doxycycline in an immediate release portion and about 10 mg doxycycline in a delayed release portion. It was surprisingly discovered that the 16-week, once daily, oral administration of about 40 mg doxycycline has achieved same or superior efficacy than that of 100 mg doxycycline, but with a significant reduction in adverse events.
    Type: Application
    Filed: March 13, 2013
    Publication date: August 1, 2013
    Inventors: Vasant Kumar MANNA, Sandrine SEGURA, Ludovic BUSSARD, Jean-Pierre ETCHEGARAY, Phil FREIDENREICH
  • Sustained-Release Tablet and Process for Preparing the Same
    Publication number: 20120100214
    Abstract: A method for producing a sustained-release tablet having improved stability and content uniformity is provided. The method involves first preparing a core tablet by granulating, drying, milling, blending, and compressing a mixture of active and inactive ingredients. Four coating layers are applied to the core tablet: an inner layer, an enteric coating layer, an active layer, and an outer layer. The active ingredient may be a tetracycline, such as doxycycline. A sustained-release tablet prepared according to the method is also described.
    Type: Application
    Filed: October 21, 2011
    Publication date: April 26, 2012
    Applicant: Galderma S.A.
    Inventors: Sandrine SEGURA, Ludovic BUSSARD, Jean-Pierre ETCHEGARAY